z-logo
open-access-imgOpen Access
Acalabrutinib : une véritable avancée pour la prise en charge de la leucémie lymphoïde chronique en rechute ou réfractaire?
Author(s) -
Laly Nsiala,
Cécile Tomowiak
Publication year - 2020
Publication title -
hématologie
Language(s) - French
Resource type - Journals
eISSN - 1766-0327
pISSN - 1264-7527
DOI - 10.1684/hma.2020.1557
Subject(s) - medicine , political science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom